Evening Dosing Is Associated With Higher Plasma Concentrations of Pranlukast, a Leukotriene Receptor Antagonist, in Healthy Male Volunteers

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.1997.00650.x

Related search